advertisement

Topcon

9.4.1 Steroid-induced glaucoma (13)

Showing records 1 to 13

Display all abstracts in classification 9.4.1 Steroid-induced glaucoma

Search within classification 9.4.1 Steroid-induced glaucoma
58768 Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Investigative Ophthalmology and Visual Science 2014; 55: 4922-4933
58735 Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clinical and Experimental Ophthalmology 2015; 43: 54-66
59115 Safety considerations of inhaled corticosteroids in the elderly
Battaglia S; Cardillo I; Lavorini F; Spatafora M; Scichilone N
Drugs and Aging 2014; 31: 787-796
59619 NFATc1 activity regulates the expression of myocilin induced by dexamethasone
Faralli JA; Clark RW; Filla MS; Peters DM
Experimental Eye Research 2014; 130: 9-16
58445 Evaluation of retinal nerve fiber layer thickness in vernal keratoconjunctivitis patients under long-term topical corticosteroid therapy
Cingu AK; Cinar Y; Turkcu FM; Sahinoglu-Keskek N; Sahin A; Sahin M; Yuksel H; Caca I
Cutaneous and Ocular Toxicology 2014; 33: 184-188
58902 Over-the-counter migration of steroid use: impact on the eye
Bielory B; Bielory L
Current opinion in allergy and clinical immunology 2014; 14: 471-476
59314 Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep
Candia OA; Gerometta RM; Danias J
Experimental Eye Research 2014; 128: 114-116
59301 Steroid treatment and risk of glaucoma
Jeppesen P; Krag S
Ugeskrift for Laeger 2014; 176:
58855 IMPACT ON INTRAOCULAR PRESSURE AFTER 20-MG DECANTED TRIAMCINOLONE ACETONIDE (KENALOG) INJECTION WHEN USING PROPHYLACTIC ANTIGLAUCOMA THERAPY
Barteselli G; Amini P; Ezon IC; Nezgoda JT; Cheng L; Freeman WR
Retina (Philadelphia, Pa.) 2015; 35: 75-81
59117 Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clinical and Experimental Ophthalmology 2015; 43: 234-238
58755 Periocular corticosteroid injections in uveitis: effects and complications
Sen HN; Vitale S; Gangaputra SS; Nussenblatt RB; Liesegang TL; Levy-Clarke GA; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Kempen JH
Ophthalmology 2014; 121: 2275-2286
59616 Uveitis in Behçet Disease in a Tertiary Center Over 25 Years: The KKESH Uveitis Survey Study Group
Arevalo JF; Lasave AF; Al Jindan MY; Al Sabaani NA; Al-Mahmood AM; Al-Zahrani YA; Al Dhibi HA;
American Journal of Ophthalmology 2015; 159: 177-184.e2
58957 Steroid-induced ocular hypertensive response in children and adolescents with acute lymphoblastic leukemia and non-Hodgkin lymphoma
de Queiroz Mendonca C; de Souza CP; Martins-Filho PR; Viana SS; Leal BC; Cipolotti R
Pediatric Blood and Cancer 2014; 61: 2083-2085

Issue 16-3

Change Issue


advertisement

Oculus